Percutaneous transluminal coronary angioplasty in [**2172**] for coronary artery disease.
Status post appendectomy and cholecystectomy.
Lisinopril 20 mg po q day.
Labetalol 100 mg po b.i.d.
Verapamil SR 120 mg po q day.
Dyazide 37.5/2.5 Monday and Thursday.
Glipizide 10 po q day.
Somantadine 400 b.i.d.
Fexofenadine 60 b.i.d.
Iron sulfate 325 mg b.i.d.
Antevert 12.5 mg po b.i.d.
Quinapril 150 po b.i.d.
Enteric coated aspirin 325 mg po q day.
Colace 100 mg po b.i.d.
As part of a experimental study here at the [**Hospital1 69**] caused DIFUSE, she was given intravenous tissue plasminogen activator.
There is a larger area of a diffusion flowing appreciated on diffusion sensitive sequences.
However, what is clear is that a transesophageal echocardiogram done at the time of cardioversion revealed no evidence of atrial disease or thrombus present.
To evaluate for any changes post cardioversion and catheterization Mrs. [**Known lastname 39648**] is undergoing a surface cardiac echocardiogram today the results of which are still pending.
One may also consider the addition of Aggrenox via the extended release formulation of aspirin and Dipridamole and this will be considered at her next visit with her neurology physicians as well as the Stroke Service.
At the time of this dictation Mrs. [**Known lastname 39648**] is clinically stable and appropriate for transfer to a rehabilitation facility for an emphasis on improving her hemiparesis after her right sided MCA infarction.
Right MCA ischemic infarction status post IVTPA as part of the DIFUSE study.
Coronary artery disease status post percutaneous transluminal coronary angioplasty in [**2172**].
Iron deficiency anemia with colonoscopy as scheduled.
Enteric coated aspirin 325 mg po q day.
Lisinopril 20 mg po q day.
Verapamil SR 120 mg po q day.
Labetalol 100 mg po b.i.d.
Dyazide 37.5/2.5 po q Monday and Thursday.
Glipizide 10 mg po q day.
Fexofenadine 60 mg po q day.
Ferrous sulfate 325 mg po q day.
Antevert 12.5 mg po b.i.d.
Protonix 40 mg po q day.
Colace 100 mg po b.i.d.
Dulcolax 10 mg po prn q day.
